A detailed history of Aletheian Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aletheian Wealth Advisors LLC holds 1,856 shares of ABBV stock, worth $321,125. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,856
Previous 1,854 0.11%
Holding current value
$321,125
Previous $317,000 15.46%
% of portfolio
0.22%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$163.84 - $199.33 $327 - $398
2 Added 0.11%
1,856 $366,000
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $37,923 - $44,286
245 Added 15.23%
1,854 $317,000
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $39,315 - $44,796
246 Added 18.05%
1,609 $292,000
Q4 2023

Jan 05, 2024

SELL
$137.6 - $154.97 $8,668 - $9,763
-63 Reduced 4.42%
1,363 $211,000
Q3 2023

Oct 04, 2023

BUY
$133.59 - $154.65 $190,499 - $220,530
1,426 New
1,426 $212,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aletheian Wealth Advisors LLC Portfolio

Follow Aletheian Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aletheian Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aletheian Wealth Advisors LLC with notifications on news.